Lorazepam Tablet
Product Images NDC 71610-178

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 71610-178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 2 mg (71610 0178 15)

Label for Lorazepam, USP 2 mg tablets, containing 15 tablets. The label includes a warning about habit-forming potential, storage instructions, and manufacturer information showing Leading Pharma, LLC in Fairfield, NJ. The product is repackaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The label displays the product NDC 71610-0178-15 and indicates prescription use only.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Lorazepam Structure (Lorazepam Structure)

Chemical structure of lorazepam showing its molecular formula C15H10Cl2N2O2 and a molecular weight of 321.16. The diagram includes two aromatic rings, two chlorine atoms, and functional groups characteristic of lorazepam.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.